You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

NANDROLONE DECANOATE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for NANDROLONE DECANOATE?
  • What are the global sales for NANDROLONE DECANOATE?
  • What is Average Wholesale Price for NANDROLONE DECANOATE?
Summary for NANDROLONE DECANOATE
Drug patent expirations by year for NANDROLONE DECANOATE
Recent Clinical Trials for NANDROLONE DECANOATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
National Institute of Geriatrics, Rheumatology and Rehabilitation, PolandPhase 2
Medical Research Agency, PolandPhase 2
King Edward Medical UniversityN/A

See all NANDROLONE DECANOATE clinical trials

US Patents and Regulatory Information for NANDROLONE DECANOATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abraxis Pharm NANDROLONE DECANOATE nandrolone decanoate INJECTABLE;INJECTION 088290-001 Oct 3, 1983 DISCN No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Watson Labs NANDROLONE DECANOATE nandrolone decanoate INJECTABLE;INJECTION 088554-001 Feb 10, 1986 DISCN No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Epic Pharma Llc NANDROLONE DECANOATE nandrolone decanoate INJECTABLE;INJECTION 087519-001 Sep 28, 1983 DISCN No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Watson Labs NANDROLONE DECANOATE nandrolone decanoate INJECTABLE;INJECTION 086598-001 Jan 13, 1984 DISCN No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

NANDROLONE DECANOATE Market Analysis and Financial Projection Experimental

Market Dynamics and Financial Trajectory of Nandrolone Decanoate

Introduction

Nandrolone decanoate, a synthetic anabolic steroid, is gaining significant traction in both medical and athletic fields. Its versatility in treating various medical conditions and enhancing physical performance has made it a crucial component in the pharmaceutical and sports industries.

Market Size and Growth

The nandrolone decanoate market was valued at USD 100 billion in 2023 and is projected to reach USD 140.71 billion by 2031, growing at a Compound Annual Growth Rate (CAGR) of 5% from 2024 to 2031[1][4][5].

Segmentation

The market is segmented based on type, application, and geography.

By Type

  • Injectable Grade: Primarily used for medical and athletic purposes.
  • Pharmaceutical Grade: Used in the production of various pharmaceutical products.
  • Research Grade: Utilized in scientific research and development[1].

By Application

  • Anabolic Steroids: Used for muscle building and performance enhancement.
  • Muscle Building: Popular among bodybuilders and athletes.
  • Hormone Therapy: Used to treat conditions such as male hypogonadism.
  • Sports Medicine: Employed to enhance athletic performance and aid in recovery[1][4].

By Geography

The market is spread across North America, Europe, Asia-Pacific, South America, and the Middle-East and Africa. The Asia-Pacific region is witnessing rapid growth due to increasing awareness of anabolic steroids and a growing number of fitness enthusiasts[1][4].

Driving Factors

Several factors are driving the growth of the nandrolone decanoate market:

Medical Uses

Nandrolone decanoate is used to treat various medical conditions, including anemia, chronic kidney disease (CKD), osteoporosis, male hypogonadism, and AIDS-associated wasting syndrome. Its efficacy in increasing hemoglobin and hematocrit levels, as well as body mass and strength, makes it a valuable therapeutic agent[2][4].

Fitness and Bodybuilding Trends

The global trend of increased fitness awareness and the rising popularity of bodybuilding are significant drivers. Athletes and bodybuilders use nandrolone decanoate to enhance physical performance and muscle mass[1][4].

Technological Advancements

Innovations in drug delivery systems, such as sustained-release formulations and transdermal patches, are making nandrolone decanoate more convenient and safer to use. These advancements are enhancing patient compliance and expanding the market[4].

Regulatory Approvals

Increasing regulatory approvals are legitimizing the market, encouraging more pharmaceutical companies to invest in the development and commercialization of nandrolone decanoate products. This shift is crucial for market growth and investor confidence[4].

Market Trends

New Product Launches

Recent years have seen the launch of new products with improved formulations, such as sustained-release injections and transdermal patches. These innovations offer better efficacy and reduced side effects, making the drug more appealing to a broader range of users[4].

Mergers and Acquisitions

Pharmaceutical companies are engaging in mergers and acquisitions to expand their product portfolios and gain a competitive edge. These strategic moves are helping to consolidate the market and lead to greater efficiencies and more robust product offerings[4].

Strategic Partnerships

Collaborations among pharmaceutical companies are facilitating the development of more effective and safer nandrolone decanoate products. These partnerships also help companies navigate the complex regulatory landscape, accelerating the approval and commercialization of new products[4].

Regional Analysis

North America

Driven by the increasing prevalence of chronic diseases and the rising popularity of bodybuilding, North America is a significant market for nandrolone decanoate[4].

Europe

Europe has a strong market presence due to the high demand for performance-enhancing drugs in sports. The region's stringent regulatory environment also supports the market's growth[4].

Asia-Pacific

The Asia-Pacific region is experiencing rapid market expansion due to growing awareness of anabolic steroids and an increasing number of fitness enthusiasts. This region is expected to be a key growth area in the coming years[1][4].

Financial Outlook

The nandrolone decanoate market presents a lucrative investment opportunity due to its expanding demand across both medical and athletic sectors. The market's growth is supported by several factors, including:

  • Increasing Prevalence of Chronic Diseases: The rising number of patients with chronic diseases such as anemia, CKD, and osteoporosis is driving the demand for nandrolone decanoate.
  • Rising Popularity of Fitness and Bodybuilding: The growing trend of fitness awareness and bodybuilding is increasing the demand for performance-enhancing drugs.
  • Advancements in Drug Delivery Systems: Innovations in drug delivery are making nandrolone decanoate more convenient and safer, thereby increasing its adoption.
  • Regulatory Approvals: Increasing regulatory approvals are legitimizing the market and encouraging more investment in the development and commercialization of nandrolone decanoate products[1][4].

Key Players

The market includes prominent players such as Organon International, Pfizer Inc., Gen-Shi Laboratories, Dragon Pharma, Beligas Pharmaceuticals, Zhengzhou Pharmaceuticals, and Geneza Pharmaceuticals. These companies are profiled based on their market entry year, product offerings, and various market-related factors[1].

Conclusion

The nandrolone decanoate market is poised for significant growth, driven by its medical and athletic applications, technological advancements, and regulatory approvals. As the market continues to expand, it offers a promising investment opportunity with potential for high returns.

Key Takeaways

  • The nandrolone decanoate market is valued at USD 100 billion in 2023 and is expected to reach USD 140.71 billion by 2031.
  • The market is driven by medical uses, fitness trends, technological advancements, and regulatory approvals.
  • Key segments include injectable grade, pharmaceutical grade, and research grade, with applications in anabolic steroids, muscle building, hormone therapy, and sports medicine.
  • North America, Europe, and the Asia-Pacific region are significant markets.
  • Innovations in drug delivery systems and strategic partnerships are key trends.
  • The market presents a lucrative investment opportunity due to its expanding demand and technological advancements.

FAQs

  1. What are the primary medical uses of nandrolone decanoate?

    • Nandrolone decanoate is used to treat conditions such as anemia, chronic kidney disease (CKD), osteoporosis, male hypogonadism, and AIDS-associated wasting syndrome[2][4].
  2. How is the nandrolone decanoate market segmented?

    • The market is segmented by type (injectable grade, pharmaceutical grade, research grade), application (anabolic steroids, muscle building, hormone therapy, sports medicine), and geography (North America, Europe, Asia-Pacific, etc.)[1].
  3. What are the key drivers of the nandrolone decanoate market?

    • The market is driven by medical uses, fitness and bodybuilding trends, technological advancements in drug delivery systems, and increasing regulatory approvals[1][4].
  4. Which regions are expected to see significant growth in the nandrolone decanoate market?

    • North America, Europe, and the Asia-Pacific region are expected to be key growth areas due to increasing demand and awareness[1][4].
  5. What are some recent trends in the nandrolone decanoate market?

    • Recent trends include the launch of new products with improved formulations, mergers and acquisitions among pharmaceutical companies, and a growing focus on compliance and safety[4].

Sources

  1. Market Research Intellect - Nandrolone Decanoate Market Size, Share, Trends, Analysis, 2031
  2. University of Maryland, Baltimore - Nandrolone decanoate
  3. The Journal of Clinical Endocrinology & Metabolism - Analysis of Serum and Urine Samples in Healthy Men
  4. Market Research Intellect - Nandrolone Decanoate Market Surges: A New Era in Muscle Building Pharmaceuticals
  5. News Channel Nebraska - Global Nandrolone Decanoate Market Size 2024: Research Report

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.